Cetera Investment Advisers’s Virtus Biotech ETF BBP Stock Holding History

Cetera Investment Advisers’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.7M	Buy	17,685 +995	+6%	+$86.6K	﹤0.01%	2527
2026 Q1	$1.39M	Buy	16,690 +10,986	+193%	+$903K	﹤0.01%	2620
2025 Q4	$456K	Buy	5,704 +813	+17%	+$61.7K	﹤0.01%	3516
2025 Q3	$342K	Buy	4,891 +209	+4%	+$13.7K	﹤0.01%	3724
2025 Q2	$273K	Buy	4,682 +141	+3%	+$7.97K	﹤0.01%	3480
2025 Q1	$266K	Buy	4,541 +1,175	+35%	+$72.1K	﹤0.01%	3375
2024 Q4	$202K	Buy	+3,366	New	+$213K	﹤0.01%	3422

Other funds holding BBP

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

WBI Investments Red Bank, New Jersey $403M AUM 42.23% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

Cetera Investment Advisers's BBP Position: Q2 2026 in Review

Cetera Investment Advisers increased its Virtus Biotech ETF (BBP) stake by 6% in Q2 2026, buying an estimated $86.6K and bringing the position to 17,685 shares worth $1.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2527.

Cetera Investment Advisers first reported a position in BBP in Q4 2024 and has held it in 7 quarters since. 25 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

Cetera Investment Advisers held 17,685 shares of Virtus Biotech ETF worth $1.7M as of Q2 2026.
Cetera Investment Advisers bought 995 Virtus Biotech ETF shares in Q2 2026, an estimated $86.6K.
Virtus Biotech ETF made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2527 holding.
Cetera Investment Advisers first reported a position in Virtus Biotech ETF in Q4 2024 and has held it in 7 quarters since.
25 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.